Effects of 60 minutes of hyperoxia followed by normoxia before coronary artery bypass grafting on the inflammatory response profile and myocardial injury

Journal of Negative Results in BioMedicine

Volumn 11, Issue 1, 2012, Pages

  Karu, Inga ^a,b   Tähepld, Peeter ^b,c   Ruusalepp, Arno ^b,c   Zilmer, Kersti ^d   Zilmer, Mihkel ^d   Starkopf, Joel ^b,c  

^a North Estonia Medical Centre   (Estonia)

^b UNIVERSITY OF TARTU   (Estonia)

^c TARTU UNIVERSITY HOSPITAL   (Estonia)

^d Faculty of Medicine   (Estonia)

Author keywords

Coronary artery bypass grafting; Cytokine; Hyperoxia; Interferon gamma; Interleukin; Preconditioning; Troponin T; Tumor necrosis factor alfa

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; OXYGEN; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

AORTA CLAMPING; ARTICLE; ASSISTED VENTILATION; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CYTOKINE RELEASE; FEMALE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; HYPEROXIA; INFLAMMATION; ISCHEMIC PRECONDITIONING; MALE; OXIDATIVE STRESS; POSTOPERATIVE PERIOD;

AGED; CORONARY ARTERY BYPASS; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN; POSTOPERATIVE PERIOD; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866172190     PISSN: None     EISSN: 14775751     Source Type: Journal    
DOI: 10.1186/1477-5751-11-14     Document Type: Article

References (30)

1. Pretreatment by hyperoxia-a tool to reduce ischaemia-reperfusion injury in the myocardium. Karu I, Tähepld P, Ruusalepp A, Starkopf J, Curr Clin Pharmacol 2010 5 125 132 10.2174/157488410791110788 20156153
2. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Tähepld P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J, Life Sci 2001 68 1629 1640 10.1016/S0024-3205(01)00964-X 11263675
3. Hyperoxia confers myocardial protection in mechanically ventilated rats through the generation of free radicals and opening of mitochondrial ATP-sensitive potassium channels. Colantuono G, Tiravanti EA, Di Venosa N, Cazzato A, Rastaldo R, Cagiano R, D'Agostino D, Federici A, Fiore T, Clin Exp Pharmacol Physiol 2008 35 64 71 10.1111/j.1440-1681.2007.04745.x 18047630
4. Preconditioning protects the severely atherosclerotic mouse heart. Li G, Tokuno S, Tähepld P, Vaage J, Löwbeer C, Valen G, Ann Thorac Surg 2001 71 1296 1304 10.1016/S0003-4975(00)02608-4 11308177
5. Cardioprotection by breathing hyperoxic gas - relation to oxygen concentration and exposure time in rats and mice. Tähepld P, Ruusalepp A, Li G, Vaage J, Starkopf J, Valen G, Eur J Cardiothor Surg 2002 21 987 994 10.1016/S1010-7940(02)00125-2
6. Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats. Esmaili Dehaj M, Baharvand B, Rasoulian B, Foadaddini M, Asgari A, Noroozzadeh A, Poorkhalili K, Wahhab Aghai H, Khoshbaten A, J Surg Res 2009 151 55 61 10.1016/j.jss.2007.12.802 18619620
7. Preconditioning effects of steroids and hyperoxia on cardiac ischemia-reperfusion injury and vascular reactivity. Kaljusto ML, Stensløkken KO, Mori T, Panchenko A, Frantzen ML, Valen G, Vaage J, Eur J Cardiothorac Surg 2008 33 355 363 10.1016/j.ejcts.2007.12.017 18221880
8. Exposure of rats to hyperoxia enhances relaxation of isolated aortic rings and reduces infarct size of isolated hearts. Tähepld P, Elfström P, Eha I, Kals J, Taal G, Talonpoika A, Valen G, Vaage J, Starkopf J, Acta Physiol Scand 2002 175 271 277 10.1046/j.1365-201X.2002.01002.x 12167166
9. Ischemia and reperfusion-induced arrhythmias: role of hyperoxic preconditioning. Pourkhalili K, Hajizadeh S, Tiraihi T, Akbari Z, Esmailidehaj M, Bigdeli MR, Khoshbaten A, J Cardiovasc Med (Hagerstown) 2009 10 635 642 10.2459/JCM.0b013e32832997f3
10. Pretreatment with hyperoxia reduces in vivo infarct size and cell death by apoptosis with an early and delayed phase of protection. Foadoddini M, Esmailidehaj M, Mehrani H, Sadraei SH, Golmanesh L, Wahhabaghai H, Valen G, Khoshbaten A, Eur J Cardiothorac Surg 2011 39 233 240 10.1016/j.ejcts.2010.05. 036 20655755
11. Pre-treatment with hyperoxia before coronary artery bypass grafting-effects on myocardial injury and inflammatory response. Karu I, Loit R, Zilmer K, Kairane C, Paapstel A, Zilmer M, Starkopf J, Acta Anaesthesiol Scand 2007 51 1305 1313 10.1111/j.1399-6576.2007.01444.x 17944632
12. Duality of innate stress responses in cardiac injury, repair, and remodeling. Wilson EM, Diwan A, Spinale FG, Mann DL, J Mol Cell Cardiol 2004 37 801 811 10.1016/j.yjmcc.2004.05.028 15380670
13. Innate immunity and inflammation-New frontiers in comparative cardiovascular pathology. Linde A, Mosier D, Blecha F, Melgarejo T, Cardiovasc Res 2007 73 26 36 10.1016/j.cardiores.2006.08.009 17010957
14. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Wan S, LeClerc JL, Schmartz D, Barvais L, Huynh CH, Devière J, DeSmet JM, Vincent JL, Am Heart J 1997 133 335 339 10.1016/S0002-8703(97)70229-1 9060803
15. Cardiac preconditioning for ischaemia: lost in translation. Ludman AJ, Yellon DM, Hausenloy DJ, Dis Model Mech 2010 3 35 38 10.1242/dmm.003855 20075380
16. Of mice and men: comparative proteomics of bronchoalveolar fluid. Gharib SA, Nguyen E, Altemeier WA, Shaffer SA, Doneanu CE, Goodlett DR, Schnapp LM, Eur Respir J 2010 35 1388 1395 10.1183/09031936.00089409 20032019
17. Preconditioning in isolated superfused human muscle. Walker DM, Walker JM, Pugsley WB, Pattison CW, Yellon DM, J Mol Cell Cardiol 1995 27 1349 1357 10.1016/S0022-2828(05)82397-1 8531217
18. Statins and cardioprotection More than just lipid lowering? Ludman A, Venugopal V, Derek M, Yellon D, Derek J, Hausenloy D, Pharmacol Ther 2009 122 30 43 10.1016/j.pharmthera.2009.01.002 19318042
19. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G, Covino E, Ann Thorac Surg 2007 83 1374 1380 10.1016/j.athoracsur.2006.10.065 17383342
20. Impact of angiotensin converting enzyme inhibition on post-coronary artery bypass interleukin 6 release. Brull DJ, Sanders J, Rumley A, Lowe GD, Humphries SE, Montgomery HE, Heart 2002 87 252 255 10.1136/heart.87.3.252 11847165
21. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery. Benedetto U, Melina G, Capuano F, Comito C, Bianchini R, Simon C, Refice S, Angeloni E, Sinatra R, Cardiovasc Med (Hagerstown) 2008 9 1098 1103 10.2459/JCM.0b013e32830a6daf
22. Revisiting the role of tumor necrosis factor alpha and the response to surgical injury and inflammation. Ksontini R, MacKay SL, Moldawer LL, Arch Surg 1998 133 558 567 10.1001/archsurg.133.5.558 9605921
23. Interplay of TNF- and IL-10 in regulating oxidative stress in isolated adult cardiac myocytes. Kaur K, Sharma AK, Dhingra S, Singal PK, J Mol Cell Cardiol 2006 41 1023 1030 10.1016/j.yjmcc.2006.08.005 17045606
24. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Bolger AP, Sharma R, von Haehling S, Doehner W, Oliver B, Rauchhaus M, Coats AJ, Adcock IM, Anker SD, Am J Card 2002 90 384 389 10.1016/S0002-9149(02)02494-3 12161227
25. Interleukin-10-mediated inhibition of free radical generation in macrophages. Dokka S, Shi X, Leonard S, Wang L, Castranova V, Rojanasakul Y, Am J Physiol Lung Cell Mol Physiol 2001 280 1196 L1202 11350798
26. Protective effects of L-4 and IL-10 against immune complex-induced lung injury. Mulligan MS, Jones ML, Vaporciyan AA, Howard MC, Ward PA, J Immunol 1993 151 5666 5674 7901280
27. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. Shanley TP, Schmal H, Friedl HP, Jones ML, Ward PA, J Immunol 1995 154 3454 3460 7897226
28. Tumor necrosis factor-alpha and interleukin-10 gene expression in peripheral blood mononuclear cells after cardiac surgery. Duggan E, Caraher E, Gately K, O'Dwyer M, McGovern E, Kelleher D, McManus R, Ryan T, Crit Care Med 2006 34 2134 2139 10.1097/01.CCM.0000227647.77356.AB 16763510
29. Proinflammatory and antiinflammatory cytokines after cardiac operation: different cellular sources at different times. Franke A, Lante W, Fackeldey V, Becker HP, Thode C, Kuhlmann WD, Markewitz A, Ann Thorac Surg 2002 74 363 370 10.1016/S0003-4975(02)03658-5 12173814
30. Is interferon gamma suppression after cardiac surgery caused by a decreased interleukin-12 synthesis? Franke A, Lante W, Kurig E, Zöller LG, Weinhold C, Markewitz A, Ann Thorac Surg 2006 82 103 109 10.1016/j.athoracsur. 2006.02.042 16798198